Literature DB >> 31501181

Canadian guideline for Parkinson disease.

David Grimes1, Megan Fitzpatrick2, Joyce Gordon2, Janis Miyasaki2, Edward A Fon2, Michael Schlossmacher2, Oksana Suchowersky2, Alexander Rajput2, Anne Louise Lafontaine2, Tiago Mestre2, Silke Appel-Cresswell2, Suneil K Kalia2, Kerrie Schoffer2, Mateusz Zurowski2, Ronald B Postuma2, Sean Udow2, Susan Fox2, Pauline Barbeau2, Brian Hutton2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31501181      PMCID: PMC6733687          DOI: 10.1503/cmaj.181504

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  11 in total

Review 1.  The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease.

Authors:  Susan H Fox; Regina Katzenschlager; Shen-Yang Lim; Bernard Ravina; Klaus Seppi; Miguel Coelho; Werner Poewe; Olivier Rascol; Christopher G Goetz; Cristina Sampaio
Journal:  Mov Disord       Date:  2011-10       Impact factor: 10.338

Review 2.  AGREE II: advancing guideline development, reporting and evaluation in health care.

Authors:  Melissa C Brouwers; Michelle E Kho; George P Browman; Jako S Burgers; Francoise Cluzeau; Gene Feder; Béatrice Fervers; Ian D Graham; Jeremy Grimshaw; Steven E Hanna; Peter Littlejohns; Julie Makarski; Louise Zitzelsberger
Journal:  CMAJ       Date:  2010-07-05       Impact factor: 8.262

Review 3.  MDS clinical diagnostic criteria for Parkinson's disease.

Authors:  Ronald B Postuma; Daniela Berg; Matthew Stern; Werner Poewe; C Warren Olanow; Wolfgang Oertel; José Obeso; Kenneth Marek; Irene Litvan; Anthony E Lang; Glenda Halliday; Christopher G Goetz; Thomas Gasser; Bruno Dubois; Piu Chan; Bastiaan R Bloem; Charles H Adler; Günther Deuschl
Journal:  Mov Disord       Date:  2015-10       Impact factor: 10.338

4.  Parkinson's disease: Prevalence, diagnosis and impact.

Authors:  Suzy L Wong; Heather Gilmour; Pamela L Ramage-Morin
Journal:  Health Rep       Date:  2014-11       Impact factor: 4.796

Review 5.  Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease.

Authors:  J J Ferreira; R Katzenschlager; B R Bloem; U Bonuccelli; D Burn; G Deuschl; E Dietrichs; G Fabbrini; A Friedman; P Kanovsky; V Kostic; A Nieuwboer; P Odin; W Poewe; O Rascol; C Sampaio; M Schüpbach; E Tolosa; C Trenkwalder; A Schapira; A Berardelli; W H Oertel
Journal:  Eur J Neurol       Date:  2013-01       Impact factor: 6.089

6.  Canadian Guidelines on Parkinson's Disease.

Authors:  David Grimes; Joyce Gordon; Barbara Snelgrove; Ivy Lim-Carter; Edward Fon; Wayne Martin; Marguerite Wieler; Oksana Suchowersky; Alex Rajput; Anne L Lafontaine; Jon Stoessl; Elena Moro; Kerrie Schoffer; Janis Miyasaki; Doug Hobson; Minoo Mahmoudi; Susan Fox; Ron Postuma; Hrishikesh Kumar; Mandar Jog
Journal:  Can J Neurol Sci       Date:  2012-07       Impact factor: 2.104

7.  Longitudinal analysis of impulse control disorders in Parkinson disease.

Authors:  Jean-Christophe Corvol; Fanny Artaud; Florence Cormier-Dequaire; Olivier Rascol; Franck Durif; Pascal Derkinderen; Ana-Raquel Marques; Frédéric Bourdain; Jean-Philippe Brandel; Fernando Pico; Lucette Lacomblez; Cecilia Bonnet; Christine Brefel-Courbon; Fabienne Ory-Magne; David Grabli; Stephan Klebe; Graziella Mangone; Hana You; Valérie Mesnage; Pei-Chen Lee; Alexis Brice; Marie Vidailhet; Alexis Elbaz
Journal:  Neurology       Date:  2018-06-20       Impact factor: 9.910

8.  Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study.

Authors:  Ronald B Postuma; Alex Iranzo; Birgit Hogl; Isabelle Arnulf; Luigi Ferini-Strambi; Raffaele Manni; Tomoyuki Miyamoto; Wolfgang Oertel; Yves Dauvilliers; Yo-El Ju; Monica Puligheddu; Karel Sonka; Amelie Pelletier; Juan Santamaria; Birgit Frauscher; Smaranda Leu-Semenescu; Marco Zucconi; Michele Terzaghi; Masayuki Miyamoto; Marcus M Unger; Bertrand Carlander; Maria-Livia Fantini; Jacques Y Montplaisir
Journal:  Ann Neurol       Date:  2015-03-13       Impact factor: 10.422

9.  AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.

Authors:  Beverley J Shea; Barnaby C Reeves; George Wells; Micere Thuku; Candyce Hamel; Julian Moran; David Moher; Peter Tugwell; Vivian Welch; Elizabeth Kristjansson; David A Henry
Journal:  BMJ       Date:  2017-09-21

10.  Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease.

Authors:  Christel Renoux; Sophie Dell'Aniello; Paul Khairy; Connie Marras; Shawn Bugden; Tanvir Chowdhury Turin; Lucie Blais; Hala Tamim; Charity Evans; Russell Steele; Colin Dormuth; Pierre Ernst
Journal:  Br J Clin Pharmacol       Date:  2016-05-19       Impact factor: 4.335

View more
  16 in total

1.  Rapid recommendations: Updates from 2019 guidelines: part 2.

Authors:  Danielle O'Toole
Journal:  Can Fam Physician       Date:  2020-06       Impact factor: 3.275

2.  Neurologists' Attitudes Toward Use and Timing of Deep Brain Stimulation.

Authors:  Laura Yenisa Cabrera; Catherine Young Han; Tasha Ostendorf; Joohi Jimenez-Shahed; Harini Sarva
Journal:  Neurol Clin Pract       Date:  2021-12

3.  Physical Therapist Management of Parkinson Disease: A Clinical Practice Guideline From the American Physical Therapy Association.

Authors:  Jacqueline A Osborne; Rachel Botkin; Cristina Colon-Semenza; Tamara R DeAngelis; Oscar G Gallardo; Heidi Kosakowski; Justin Martello; Sujata Pradhan; Miriam Rafferty; Janet L Readinger; Abigail L Whitt; Terry D Ellis
Journal:  Phys Ther       Date:  2022-04-01

4.  Neuroprotective Effect of Ceftriaxone on MPTP-Induced Parkinson's Disease Mouse Model by Regulating Inflammation and Intestinal Microbiota.

Authors:  Xiaoting Zhou; Jiachen Lu; Kehong Wei; Jing Wei; Puyuan Tian; Mengyun Yue; Yun Wang; Daojun Hong; Fangjun Li; Bo Wang; Tingtao Chen; Xin Fang
Journal:  Oxid Med Cell Longev       Date:  2021-12-13       Impact factor: 6.543

Review 5.  Frameworks for Parkinson's Disease Rehabilitation Addressing When, What, and How.

Authors:  Miriam R Rafferty; Ella Nettnin; Jennifer G Goldman; Jillian MacDonald
Journal:  Curr Neurol Neurosci Rep       Date:  2021-02-22       Impact factor: 5.081

6.  Effectiveness and safety of moxibustion for Parkinson disease: A protocol for systematic review and meta-analysis.

Authors:  Yonghui Hou; Baile Ning; Yamin Liu; Ying Liu; Wenbin Fu; Zehuai Wen
Journal:  Medicine (Baltimore)       Date:  2021-06-11       Impact factor: 1.817

7.  Therapeutic effect of GLP-1 engineered strain on mice model of Alzheimer's disease and Parkinson's disease.

Authors:  Xin Fang; Xiaoting Zhou; Yuqing Miao; Yiwen Han; Jing Wei; Tingtao Chen
Journal:  AMB Express       Date:  2020-04-24       Impact factor: 3.298

Review 8.  Moving towards Integrated and Personalized Care in Parkinson's Disease: A Framework Proposal for Training Parkinson Nurses.

Authors:  Marlena van Munster; Johanne Stümpel; Franziska Thieken; David J Pedrosa; Angelo Antonini; Diane Côté; Margherita Fabbri; Joaquim J Ferreira; Evžen Růžička; David Grimes; Tiago A Mestre
Journal:  J Pers Med       Date:  2021-06-30

Review 9.  Artificial intelligence applications and robotic systems in Parkinson's disease (Review).

Authors:  Lacramioara Perju-Dumbrava; Maria Barsan; Daniel Corneliu Leucuta; Luminita C Popa; Cristina Pop; Nicoleta Tohanean; Stefan L Popa
Journal:  Exp Ther Med       Date:  2021-12-17       Impact factor: 2.447

10.  Functional Connectivity in Parkinson's Disease Patients with Mild Cognitive Impairment.

Authors:  Qingguang Wang; Wei He; Dinghua Liu; Bojun Han; Qitao Jiang; Jiali Niu; Yunlong Ding
Journal:  Int J Gen Med       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.